Clinical Trial Update: A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating capecitabine-containing combination chemotherapy versus surgery alone in gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED